Skip to main content
. 2017 Oct 8;28(4):945–954. doi: 10.1007/s11695-017-2953-6

Table 1.

Participant characteristics at baseline and post-RYGB

Non-obese control (N = 20) Obese pre-surgery (N = 22) Obese post-surgery (N = 22) P value control vs. pre-surgery P value pre- vs. post-surgery
Age (years)* 46.0 (2.6) 47.0 (1.2) 0.720
Sex—N (%) female 12 (60) 4 (18) 0.175†
Smoking—N (%)
 Daily 5 (25) 0 1 (5) 0.002† < 0.001‡
 Occasional 1 (5) 0 11 (52)
 Ex-smoker 2 (10) 11 (50) 9 (43)
 Never smoked 12 (60) 10 (45) 0
 Missing data 0 1 (4) 0
NSAID use—N (%) 5 (25) 10 (45) 1 (5) 0.209† 0.004§
Previous cholecystectomy—N (%) 2 (10) 4 (18) 0.665†
Weight (kg)* 71.8 (2.8) 114.8 (3.7) 86.3 (3.5) < 0.001 < 0.001
BMI (kg/m2)* 25.4 (0.5) 42.4 (1.4) 31.3 (1.2) < 0.001 < 0.001
Body fat (%)* 30.3 (1.3) 47.6 (1.0) 36.1 (1.5) < 0.001 < 0.001
Waist (cm)*
 Men 95.9 (2.9) 137.3 (2.0) 112.5 (4.5) < 0.001 0.007
 Women 83.4 (2.2)  117.5 (2.2) 91.9 (3.5) < 0.001 < 0.001
Waist to hip ratio*
 Men 0.93 (0.01) 1.07 (0.03) 0.99 (0.03) 0.001 0.067
 Women 0.82 (0.02) 0.89 (0.01) 0.84 (0.02) 0.010 0.007

Independent sample t test used to compare non-obese control and obese pre-surgery participants, unless otherwise indicated. Paired sample t test used to compare participants pre- and post-surgery, unless otherwise indicated

NSAID non-steroidal anti-inflammatory agent

*Values indicate mean (SEM)

†Fisher’s exact test

‡Wilcoxon sign test

§Related sample McNemar test